Total Voting Rights Update

RNS Number : 4772B

Circassia Pharmaceuticals Plc

31 January 2020

 

For immediate release

Circassia Pharmaceuticals plc

Total Voting Rights Update

31^st January 2020

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that the Company's issued share capital consists of 375,199,334 ordinary shares of 0.08p each in issue, each with equal voting rights.  No shares are held in treasury.  

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

-Ends-

For further information, please contact:
Circassia Pharmaceuticals plc Michael Roller, Company Secretary	[phone]

 

END

 

 

TVRBSGDBLDXDGGG